Prof. Yulia Desheva | Virology | Women Researcher Award
Head of Department | Institute Of Experimental Medicine | Russia
Yulia Desheva is a distinguished Russian virologist and professor renowned for her pioneering contributions in the field of influenza immunology. With a long-standing commitment to research and teaching, she holds dual affiliations at the Federal State Budgetary Scientific Institution “Institute of Experimental Medicine” and Saint Petersburg State University. Her work focuses on live influenza vaccines, immune response modulation, and viral gene expression. Her extensive publication record reflects a deep understanding of viral pathogenesis and public health immunology. She is known for bridging translational research with real-world applications in vaccine development. Over the decades, Dr. Desheva has gained respect in global virology circles for her expertise in studying both pandemic threats and routine influenza strains. Through her leadership, she contributes to Russia’s scientific advancements in infectious disease control and immunoprophylaxis. Her work is highly regarded for its depth, precision, and relevance to emerging viral challenges.
Professional Profile
Scopus
Orcid
Education
Yulia Desheva earned her medical degree from the Leningrad Medical Institute of Hygiene and Sanitation in Saint Petersburg, where she studied clinical medicine with a focus on virology and immunology. Her foundational education laid the groundwork for her future pursuits in experimental virology and immunoprophylaxis. The academic environment provided her with exposure to rigorous biomedical research and public health concepts, fostering a lifelong passion for combating viral diseases. Throughout her medical education, she cultivated a strong understanding of human physiology, disease mechanisms, and immunological defense, which later shaped her research in live vaccines. She was particularly interested in the intersection of hygiene, sanitation, and viral transmission, which remains central to her current scientific inquiry. Her formal training not only provided her with clinical acumen but also imbued her with the methodological rigor necessary to contribute meaningfully to global vaccine research.
Experience
Yulia Desheva has amassed extensive professional experience over decades in leading Russian scientific institutions. she has worked at the Institute of Experimental Medicine in Saint Petersburg, contributing significantly to virology through laboratory experiments, vaccine development, and translational research. Later, she joined Saint Petersburg State University, where she serves as a professor in the Department of Fundamental Problems of Medicine and Medical Technologies. In both roles, she has trained numerous students, collaborated internationally, and led innovative projects addressing viral immunity and vaccination. Her dual appointment reflects her unique ability to integrate basic research with academic mentorship. She has also contributed to national health preparedness programs and co-authored policy-supporting research during global pandemics. Her professional journey reflects a consistent dedication to scientific excellence, teamwork, and medical advancement in the domain of immunology and infectious disease prevention.
Research Interests
Yulia Desheva’s research centers on live influenza vaccines, immunological responses, and gene expression in viral infections. She is particularly focused on understanding how vaccines can provide cross-protection against evolving influenza strains and how host immune systems react under different vaccination conditions. Her interest extends to SARS-CoV-2 and its neurological and cytokine-based manifestations, placing her at the forefront of contemporary viral research. She employs both laboratory models and clinical data to explore the molecular mechanisms of immune modulation. Her interdisciplinary approach combines virology, immunopathology, and biotechnology. She also investigates mucosal immunity, adjuvant responses, and recombinant viral constructs. Her work is instrumental in developing future vaccines that are broad-spectrum, effective, and safe. Her deep insight into neuraminidase-targeted responses offers promising avenues for both therapeutic and preventive strategies against influenza and other respiratory viruses.
Awards
Yulia Desheva’s scientific output and leadership in virology clearly reflect her stature in the biomedical research community. Her long-standing affiliation with top Russian institutions and her role as professor indicate recognition by peers and institutions alike. She frequently publishes in high-impact international journals, is involved in global collaborative research, and contributes to timely studies on pandemics such as COVID-19. The sustained funding and institutional support for her work underscore her status as an accomplished and respected researcher. Her contributions to public health, especially through vaccine research and pandemic preparedness, have made her a valued scientific voice both in Russia and internationally. Her recognition stems not just from accolades but from a lifetime of impactful work and mentorship.
Top Noted Publications
Title: Pilot Study Results on Antibodies to the S- and N-Proteins of SARS-CoV-2 in Paired Sera from COVID-19 Patients with Varying Severity
Year: 2023
Cited by: 1
Title: Establishment of a Pseudovirus Platform for Neuraminidase Inhibiting Antibody Analysis
Year: 2023
Cited by: 1
Title: Antigenic Characterization of Neuraminidase of Influenza A/H7N9 Viruses Isolated in Different Years
Year: 2022
Cited by: 2
Title: Live Influenza Vaccine Provides Early Protection against Homologous and Heterologous Influenza and May Prevent Post-Influenza Pneumococcal Infections in Mice
Year: 2022
Cited by: 2
Conclusion